Loading...
OTC Markets
Totals
Securities
12,299
Dollar Vol
$2.6B
Share Vol
5.4B
Trades
376,657

OTC Markets Group uses cookies and similar technologies to help us understand how you use our websites, as further disclosed in our Privacy Policy. Our Terms of Service contain important information including restrictions on your use of our websites. By clicking “Accept”, or by continuing to use our websites, you consent to the use of cookies and agree to the terms of the OTC Markets Group Privacy Policy and Terms of Service.

IOVA
Iovance Biotherapeutics, Inc.

Common Stock

2.34

0.11

4.93%

Delayed (15 Min) Trade Data: 12:00am 07/17/2025
Iovance Biotherapeutics, Inc. Company Logo

825 Industrial Road

Suite 100

San Carlos, CA 94070

www.lionbio.com

(650) 260-7120

Business Description
Not available
Financial Reporting
Reporting Status
U.S. Reporting: SEC Reporting
Audited Financials
Audited
Latest Report
CIK
0001425205
Fiscal Year End
12/31
Company Officers & Contacts
Manish Singh
CEO

Merrill A. McPeak
Interim CEO

Elma Hawkins
COO

Michael Handelman
CFO

Board of Directors
Jay Venkatesan
Chairman

Sanford Hillsberg

Ryan D. Maynard

Merrill A. McPeak
Interim CEO

Other Company Insiders

Not available

Other Company Insiders are all persons or entities beneficially owning 10% or more of any class of the issuer's securities. Together, officers, directors and other company insiders comprise Company Insiders.
Service Providers
Accounting/Auditing Firm
Weinberg & Company

1925 Century Park E.

Suite 1120

Los Angeles, CA 90067

Investor Relations/Marketing/Communications
LHA Advisors, Inc.

800 Third Avenue

17th Floor

New York, NY 10022

Investor Relations/Marketing/Communications
The Trout Group

740 Broadway

9th Floor

New York, NY 10003

Securities Counsel
TroyGould PC

1801 Century Park East,

Suite 1600

Los Angeles, CA 90067-2367

Profile Data
SIC - Industry Classification
2836 - Biological products, except diagnostic
Incorporation Information
DE, US
Employees
Not Available
Shell
No
Products and Services

Not available

Company Facilities

Not available

Company Notes
Formerly=Lion Biotechnologies, Inc. until 6-2017
Domicile change from NV to Delaware 6/7/2017
Formerly=Genesis Biopharma, Inc. until 9-2013
Formerly=Freight Management Corp. until 4-2010
Nasdaq
Daily Advancers
Subscribe to Our Newsletter
Stay up to date on the latest company news, industry trends and regulatory changes that affect our markets and learn about members of our community.